FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591008484> ?p ?o ?g. }

• W2591008484 endingPage "9" @default.
• W2591008484 startingPage "9" @default.
• W2591008484 abstract "The aim of this pilot study is to evaluate sarcosine, uracil, and kynurenic acid in urine as potential biomarkers in prostate cancer detection and progression monitoring. Sarcosine, uracil, and kynurenic acid were measured in urine samples of 32 prostate cancer patients prior to radical prostatectomy, 101 patients with increased prostate-specific antigen prior to ultrasonographically-guided prostatic biopsy collected before and after prostatic massage, and 15 healthy volunteers (controls). The results were related to histopathologic data, Gleason score, and PSA (Prostate Specific Antigen). Metabolites were measured after analysis of urine samples with Ultra-High Performance Liquid Chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) instrumentation. Multivariate, nonparametric statistical tests including receiver operating characteristics analyses, one-way analysis of variance (Kruskal–Wallis test), parametric statistical analysis, and Pearson correlation, were performed to evaluate diagnostic performance. Decreased median sarcosine and kynurenic acid and increased uracil concentrations were observed for patients with prostate cancer compared to participants without malignancy. Results showed that there was no correlation between the concentration of the studied metabolites and the cancer grade (Gleason score <7 vs. ≥7) and the age of the patients. Evaluation of biomarkers by ROC (Receiving Operating Characteristics) curve analysis showed that differentiation of prostate cancer patients from participants without malignancy was not enhanced by sarcosine or uracil levels in urine. In contrast to total PSA values, kynurenic acid was found a promising biomarker for the detection of prostate cancer particularly in cases where collection of urine samples was performed after prostatic massage. Sarcosine and uracil in urine samples of patients with prostate cancer were not found as significant biomarkers for the diagnosis of prostate cancer. None of the three metabolites can be used reliably for monitoring the progress of the disease." @default.
• W2591008484 created "2017-03-03" @default.
• W2591008484 creator A5000883121 @default.
• W2591008484 creator A5006492102 @default.
• W2591008484 creator A5021188315 @default.
• W2591008484 creator A5023029841 @default.
• W2591008484 creator A5067669465 @default.
• W2591008484 creator A5073904636 @default.
• W2591008484 creator A5074276294 @default.
• W2591008484 date "2017-02-23" @default.
• W2591008484 modified "2023-10-14" @default.
• W2591008484 title "The Role of Sarcosine, Uracil, and Kynurenic Acid Metabolism in Urine for Diagnosis and Progression Monitoring of Prostate Cancer" @default.
• W2591008484 cites W1481198138 @default.
• W2591008484 cites W1519781645 @default.
• W2591008484 cites W1569455139 @default.
• W2591008484 cites W1935839407 @default.
• W2591008484 cites W1969889522 @default.
• W2591008484 cites W1972395654 @default.
• W2591008484 cites W1977737642 @default.
• W2591008484 cites W1980441084 @default.
• W2591008484 cites W1984121561 @default.
• W2591008484 cites W1985615482 @default.
• W2591008484 cites W1995018330 @default.
• W2591008484 cites W1996487270 @default.
• W2591008484 cites W2002384741 @default.
• W2591008484 cites W2015072134 @default.
• W2591008484 cites W2053991769 @default.
• W2591008484 cites W2058532211 @default.
• W2591008484 cites W2086878322 @default.
• W2591008484 cites W2092423779 @default.
• W2591008484 cites W2093155538 @default.
• W2591008484 cites W2097834427 @default.
• W2591008484 cites W2098580343 @default.
• W2591008484 cites W2107363389 @default.
• W2591008484 cites W2120988323 @default.
• W2591008484 cites W2142983041 @default.
• W2591008484 cites W2150102193 @default.
• W2591008484 cites W2155680682 @default.
• W2591008484 cites W2160602446 @default.
• W2591008484 cites W2163133337 @default.
• W2591008484 cites W2166196020 @default.
• W2591008484 cites W2168450952 @default.
• W2591008484 doi "https://doi.org/10.3390/metabo7010009" @default.
• W2591008484 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5372212" @default.
• W2591008484 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28241496" @default.
• W2591008484 hasPublicationYear "2017" @default.
• W2591008484 type Work @default.
• W2591008484 sameAs 2591008484 @default.
• W2591008484 citedByCount "29" @default.
• W2591008484 countsByYear W25910084842017 @default.
• W2591008484 countsByYear W25910084842018 @default.
• W2591008484 countsByYear W25910084842019 @default.
• W2591008484 countsByYear W25910084842020 @default.
• W2591008484 countsByYear W25910084842021 @default.
• W2591008484 countsByYear W25910084842022 @default.
• W2591008484 countsByYear W25910084842023 @default.
• W2591008484 crossrefType "journal-article" @default.
• W2591008484 hasAuthorship W2591008484A5000883121 @default.
• W2591008484 hasAuthorship W2591008484A5006492102 @default.
• W2591008484 hasAuthorship W2591008484A5021188315 @default.
• W2591008484 hasAuthorship W2591008484A5023029841 @default.
• W2591008484 hasAuthorship W2591008484A5067669465 @default.
• W2591008484 hasAuthorship W2591008484A5073904636 @default.
• W2591008484 hasAuthorship W2591008484A5074276294 @default.
• W2591008484 hasBestOaLocation W25910084841 @default.
• W2591008484 hasConcept C121608353 @default.
• W2591008484 hasConcept C126322002 @default.
• W2591008484 hasConcept C126894567 @default.
• W2591008484 hasConcept C143998085 @default.
• W2591008484 hasConcept C170493617 @default.
• W2591008484 hasConcept C185592680 @default.
• W2591008484 hasConcept C2776235491 @default.
• W2591008484 hasConcept C2776841986 @default.
• W2591008484 hasConcept C2777756961 @default.
• W2591008484 hasConcept C2779943223 @default.
• W2591008484 hasConcept C2780026642 @default.
• W2591008484 hasConcept C2780192828 @default.
• W2591008484 hasConcept C515207424 @default.
• W2591008484 hasConcept C55493867 @default.
• W2591008484 hasConcept C67018056 @default.
• W2591008484 hasConcept C71924100 @default.
• W2591008484 hasConceptScore W2591008484C121608353 @default.
• W2591008484 hasConceptScore W2591008484C126322002 @default.
• W2591008484 hasConceptScore W2591008484C126894567 @default.
• W2591008484 hasConceptScore W2591008484C143998085 @default.
• W2591008484 hasConceptScore W2591008484C170493617 @default.
• W2591008484 hasConceptScore W2591008484C185592680 @default.
• W2591008484 hasConceptScore W2591008484C2776235491 @default.
• W2591008484 hasConceptScore W2591008484C2776841986 @default.
• W2591008484 hasConceptScore W2591008484C2777756961 @default.
• W2591008484 hasConceptScore W2591008484C2779943223 @default.
• W2591008484 hasConceptScore W2591008484C2780026642 @default.
• W2591008484 hasConceptScore W2591008484C2780192828 @default.
• W2591008484 hasConceptScore W2591008484C515207424 @default.
• W2591008484 hasConceptScore W2591008484C55493867 @default.
• W2591008484 hasConceptScore W2591008484C67018056 @default.
• W2591008484 hasConceptScore W2591008484C71924100 @default.
• W2591008484 hasIssue "1" @default.

• next